PEP-Therapy

0 followers


PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.

Industries

Headquarters

Paris, France

Employees

1-10

Links


Org chart

Antoine Prestat
Co-founder & CEO
Collapse
Jennifer Sengenès
Head of Strategy & Development
Laura Dadon
Head Of Drug Development
Michele Marzola
Director and Lead Investor

Board & advisors

Didier Decaudin
Co-founder & Scientific Advisor
Fariba Némati
Co-founder & Scientific Advisor
Angelita Rebollo
Co-founder & Scientific Advisor
Isabelle Ray-Coquard
Scientific Advisor
Mario Campone
Scientific Advisor
Jean Martinez
Scientific Advisor
Bruno Giroux
Scientific Advisor